You are here
- Home
- Total number of clinical trials
An Open-Label, Parallel-Group, Phase I Study to Compare the Pharmacokinetics of NKTR-118 Following a Single Oral Dose in Subjects with Renal Impairment and Subjects with Normal Renal Function
- Disease
- renal impairment
- Drug Name
- NKTR 118
- Generic Name
- NKTR-118
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D3820C00009
- Study Id
- D3820C00009
- ClinicalTrials.gov ID
- NCT01372826
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
